This announcement follows a bipartisan letter that Senator Collins and a group of nine members of Congress sent last month to ...

Solid Biosciences Inc. (NASDAQ:SLDB) is one of the stocks that will double in 2026. On December 4, Needham analyst Gil Blum ...

For nearly a decade, Solid has been a staunch supporter and a steering committee member of Parent Project Muscular Dystrophy’s (PPMD) committee dedicated to implementing newborn screening for Duchenne ...

Health secretary Robert F. Kennedy Jr. on Tuesday added two deadly rare diseases, Duchenne muscular dystrophy and ...

Webinar to be held Wednesday, December 17, 2025, at 1:00 p.m. ET –SAN DIEGO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc.

Today, the U.S. Department of Health and Human Services (HHS) officially added Duchenne muscular dystrophy (Duchenne) to the Recommended Uniform Screening Panel (RUSP), the national list of conditions ...

Scotland’s NHS can now offer givinostat to ambulant children with Duchenne muscular dystrophy, marking a step forward in care ...

U.S. health officials have added two deadly rare diseases to the list of conditions the government recommends states screen ...

Capricor Therapeutics said Wednesday that its cell therapy significantly improved muscle and heart function in patients with ...

"Early screening gives every child a fair chance at timely, effective care, and it delivers families the answers and ...

Investing.com -- Solid Biosciences Inc. (NASDAQ:SLDB) stock rose 1.4% in after-hours trading Tuesday after the U.S. Department of Health and Human Services (HHS) added Duchenne muscular dystrophy to ...

Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...